Story Stocks®

Updated: 02-Jun-22 14:28 ET
UiPath exceeds its prior expectations in AprQ on better-than-feared macroeconomic conditions (PATH)

UiPath (PATH +19%) is receiving a much-needed relief rally today after the company's Q1 (Apr) results came in significantly better than feared. The robotic process automation (RPA) software provider, whose shares were down over 60% as of yesterday's close, topped earnings and revenue estimates in Q1. The outperformance was achieved despite unfavorable macroeconomic conditions, particularly overseas, where over half of PATH's operations are conducted (approximately 30% in Europe alone). The company also improved its FY23 revenue outlook, which would have been even higher if not for negative foreign exchange impacts.

  • PATH's solid single-digit earnings beat and 31.6% revenue growth yr/yr to $245.07 mln jump out immediately. Q1 revs exceeded PATH's guidance of $223-225 mln considerably, partly because the company closed on a sizable deal with a customer in the health care vertical in Q1; performance also benefited from better-than-feared macroeconomic conditions.
    • Last quarter, PATH noted that the war in Ukraine was having a profound impact on the sense of security across Europe. It also stated that customers were concerned about rising interest rates. Both of those factors fed into PATH's underwhelming Q1 and FY23 guidance.
  • Strong customer growth in the over $100K in annualized recurring revenue (ARR) category was another highlight. PATH grew this metric 42% yr/yr and 5% sequentially to 1,574 customers. The company also continued to post excellent growth of 62% yr/yr and 6% sequentially in its over $1.0 mln in ARR customer base.
  • Perhaps what investors are homing in on today is PATH's upside FY23 outlook. The company sees FY23 revs of $1.085-1.090 bln, a slight bump from its prior forecast of $1.075-1.085 bln. Also, the guide would have been $20 mln higher if not for FX headwinds. The same goes for PATH's Q2 (Jul) outlook of $229-231 mln, which met analyst expectations only because of an estimated $5 mln FX hit.

That PATH outperformed during Q1 despite uneasy economic conditions in Europe is noteworthy. However, it should still be noted that macro challenges remain, especially in relation to a strong US dollar. PATH also did not sway much from its previous comments on the state of the geopolitical environment and its possible negative impacts on business operations going forward. Still, the anxiety that businesses are feeling domestically and overseas has some potential upside. For instance, rising interest rates and inflation pressure PATH's customers to become more efficient, making automation a possible solution.

Bottom line, PATH's Q1 results offer reassurance that the company can continue to post double-digit growth while maintaining healthy margins above 80%, even during a tumultuous time, boding well for its long-term future.

Cookies are essential for making our site work. By using our site, you consent to the use of these cookies. Read our cookie policy to learn more.